Axa’s Altimmune ALT Stock Holding History

Axa’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-32,600	Closed	-$321K	–	1225
2021 Q2	$321K	Buy	32,600 +19,800	+155%	+$271K	﹤0.01%	1161
2021 Q1	$181K	Buy	+12,800	New	+$207K	﹤0.01%	1179
2017 Q2	–	Sell	-1,206	Closed	-$294K	–	1237
2017 Q1	$294K	Buy	1,206 +98	+9%	+$52.4K	﹤0.01%	1162
2016 Q4	$1.08M	Buy	+1,108	New	+$993K	0.01%	889

Other funds holding ALT

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Axa's ALT Position: Q3 2021 in Review

Axa sold out of Altimmune (ALT) in Q3 2021, closing a stake of 32,600 shares — an estimated $321K sold.

Axa first reported a position in ALT in Q4 2016 and held it in 4 quarters. The position peaked at $1.08M in Q4 2016. 118 funds tracked by Wall St. Rank hold ALT as of Q3 2021.

Axa reported no remaining Altimmune position as of Q3 2021 after selling out during the quarter.
Axa sold 32,600 Altimmune shares in Q3 2021, an estimated $321K.
Axa first reported a position in Altimmune in Q4 2016 and held it in 4 quarters.
Axa's Altimmune position peaked at $1.08M in Q4 2016.
118 funds tracked by Wall St. Rank held Altimmune as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.